Nigel brings 20+ years of experience in strategic technology development, most recently as CTO and SVP of Operations in high growth, venture backed startups. He has raised over $100M venture capital, in cutting edge genomics, machine learning and 3D printing technologies that focused on precision and personalized products from consumer to multiomic platforms aimed at eradicating cancer. Prior to this, he held growing responsibilities and leadership positions in Global R&D roles for Applied Biosystems and Life Technologies, managing $100M's in R&D spend for +1,500 scientists. He is an inventor on over 50 patents, launched over 40 products, and serves as an advisor/board member for other start-up companies.
He holds a B.S. in Applied Chemistry from De Montfort University, an M.S. in Analytical Chemistry & Instrumentation from Loughborough University, and a Ph.D. in Microfluidics from Imperial College, London.
“Having devoted my career to genomics and product development, I am honored to be joining the co-founder of Illumina, and the talented team at Encodia, to build an extraordinary company that has the promise to enable the next frontier in biological information, proteomics.”